Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, February 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 169 articles:
HTML format


 

Single Articles

  1. CUI F, Hou J, Huang C, Sun X, et al
    C-Myc regulates radiation-induced G2/M cell cycle arrest and cell death in human cervical cancer cells.
    J Obstet Gynaecol Res. 2017 Feb 2. doi: 10.1111/jog.13261.
    Abstract    

    Abstract available

  2. MARNITZ S
    [Substantial advantage of CT-planned HDR brachytherapy for cervical cancer patients compared to a historical series with regard to local control and toxicity?]
    Strahlenther Onkol. 2017 Feb 1. doi: 10.1007/s00066-017-1097.
    Abstract    



  3. WANG L, Jia J, Lin L, Guo J, et al
    Predictive value of hematological markers of systemic inflammation for managing cervical cancer.
    Oncotarget. 2017 Jan 26. doi: 10.18632/oncotarget.14827.
    Abstract    

    Abstract available

  4. WARDAK S
    Human Papillomavirus (HPV) and cervical cancer.
    Med Dosw Mikrobiol. 2016;68:73-84.
    Abstract    

    Abstract available

  5. YILDIRIM M, Muller von der Grun J, Winkelmann R, Fokas E, et al
    Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.
    Strahlenther Onkol. 2017 Jan 31. doi: 10.1007/s00066-017-1102.
    Abstract    

    Abstract available

  6. BOBDEY S, Sathwara J, Jain A, Balasubramaniam G, et al
    Burden of cervical cancer and role of screening in India.
    Indian J Med Paediatr Oncol. 2016;37:278-285.
    Abstract    

    Abstract available

  7. ZHANG L, Bi Q, Deng H, Xu J, et al
    Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.
    BMC Infect Dis. 2017;17:107.
    Abstract    

    Abstract available

  8. TSUNODA AT, Marnitz S, Soares Nunes J, Mattos de Cunha Andrade CE, et al
    Incidence of Histologically Proven Pelvic and Para-Aortic Lymph Node Metastases and Rate of Upstaging in Patients with Locally Advanced Cervical Cancer: Results of a Prospective Randomized Trial.
    Oncology. 2017 Feb 1. doi: 10.1159/000453666.
    Abstract    

    Abstract available

  9. CHANDEYING N, Hanprasertpong J
    The prognostic impact of histological type on clinical outcomes of early-stage cervical cancer patients whom have been treated with radical surgery.
    J Obstet Gynaecol. 2017 Jan 31:1-8. doi: 10.1080/01443615.2016.1245279.
    Abstract    

    Abstract available

  10. BANSAL A, Das P, Kannan S, Mahantshetty U, et al
    Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India.
    Indian J Med Res. 2016;144:359-365.
    Abstract    

    Abstract available

  11. ROMANO KD, Pugh KJ, Trifiletti DM, Libby B, et al
    Transition from LDR to HDR brachytherapy for cervical cancer: Evaluation of tumor control, survival, and toxicity.
    Brachytherapy. 2017 Jan 27. pii: S1538-4721(16)30646.
    Abstract    

    Abstract available

  12. WU S, Wang L, Ren X, Pan Y, et al
    Involvement of retinoblastoma-associated protein 48 during photodynamic therapy of cervical cancer cells.
    Mol Med Rep. 2017 Jan 26. doi: 10.3892/mmr.2017.6151.
    Abstract    

    Abstract available

  13. ZHAO J, Guo Z, Wang Q, Si T, et al
    Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China.
    Infect Agent Cancer. 2017;12:8.
    Abstract    

    Abstract available

  14. PENG R, Ma R, Wang Q, Sun Y, et al
    miR-214 down-regulates ARL2 and suppresses growth and invasion of cervical cancer cells.
    Biochem Biophys Res Commun. 2017 Jan 27. pii: S0006-291X(17)30220.
    Abstract    

    Abstract available

  15. CHEN L, Wang L, Shen H, Lin H, et al
    Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition.
    Biochem Biophys Res Commun. 2017 Jan 27. pii: S0006-291X(17)30199.
    Abstract    

    Abstract available

  16. MUKAMA T, Ndejjo R, Musabyimana A, Halage AA, et al
    Women's knowledge and attitudes towards cervical cancer prevention: a cross sectional study in Eastern Uganda.
    BMC Womens Health. 2017;17:9.
    Abstract    

    Abstract available

  17. CASTLE PE, Jeronimo J, Temin S, Shastri SS, et al
    Screening to Prevent Invasive Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.
    J Clin Oncol. 2017 Jan 30:JCO2016716563. doi: 10.1200/JCO.2016.71.6563.
    Abstract    



  18. LOBASTOVA L, Kraus D, Glassmann A, Khan D, et al
    Collective cell migration of thyroid carcinoma cells: a beneficial ability to override unfavourable substrates.
    Cell Oncol (Dordr). 2017;40:63-76.
    Abstract    

    Abstract available

  19. CHENG JY, Huang EY, Hsu SN, Wang CJ, et al
    Simultaneous Integrated Boost (SIB) of the Parametrium and Cervix in Radiotherapy for Uterine Cervical Carcinoma: A Dosimetric Study Using a New Alternative Approach.
    Br J Radiol. 2016 Oct 6:20160526.
    Abstract    

    Abstract available

  20. CHANTRAGAWEE C, Achariyapota V
    Utilization of a Scored Patient-Generated Subjective Global Assessment in Detecting a Malnourished Status in Gynecologic Cancer Patients.
    Asian Pac J Cancer Prev. 2016;17:4401-4404.
    Abstract    

    Abstract available

  21. LERTVUTIVIVAT S, Chanthasenanont A, Chanthasenanont A, Muangto T, et al
    Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital.
    Asian Pac J Cancer Prev. 2016;17:4353-4356.
    Abstract    

    Abstract available

  22. DUMAS L, Ring A, Butler J, Kalsi T, et al
    Improving outcomes for older women with gynaecological malignancies.
    Cancer Treat Rev. 2016;50:99-108.
    Abstract    

    Abstract available

  23. RUENGKHACHORN I, Hanamornroongruang S, Leelaphatanadit C, Sangkarat S, et al
    Does Microinvasive Adenocarcinoma of Cervix Have Poorer Treatment Outcomes than Microinvasive Squamous Cell Carcinoma?
    Asian Pac J Cancer Prev. 2016;17:4013-7.
    Abstract    

    Abstract available

  24. JEYACHELVI K, Juwita S, Norwati D
    Human Papillomavirus Infection and its Vaccines: Knowledge and Attitudes of Primary Health Clinic Nurses in Kelantan, Malaysia.
    Asian Pac J Cancer Prev. 2016;17:3983-8.
    Abstract    

    Abstract available

  25. BODNER-ADLER B, Kimberger O, Schneidinger C, Kolbl H, et al
    Prognostic Significance of Pre-treatment Serum C-Reactive Protein Level in Patients with Adenocarcinoma of the Uterine Cervix.
    Anticancer Res. 2016;36:4691-6.
    Abstract    

    Abstract available

  26. BAKER M, Cooper DT, Behrens CF
    Evaluation of uterine ultrasound imaging in cervical radiotherapy; a comparison of autoscan and conventional probe.
    Br J Radiol. 2016 Jul 25:20160510.
    Abstract    

    Abstract available

  27. SHOBEIRI F, Javad MT, Parsa P, Roshanaei G, et al
    Effects of Group Training Based on the Health Belief Model on Knowledge and Behavior Regarding the Pap Smear Test in Iranian Women: a Quasi-Experimental Study.
    Asian Pac J Cancer Prev. 2016;17:2871-6.
    Abstract    

    Abstract available

  28. KONGSAWATVORAKUL C, Charakorn C, Paiwattananupant K, Lekskul N, et al
    Limited Impact of Music Therapy on Patient Anxiety with the Large Loop Excision of Transformation Zone Procedure - a Randomized Controlled Trial.
    Asian Pac J Cancer Prev. 2016;17:2853-6.
    Abstract    

    Abstract available

  29. ZHENG W, Xiong YH, Han J, Guo ZX, et al
    Contrast-enhanced ultrasonography of cervical carcinoma: Perfusion pattern and relationship with tumor angiogenesis.
    Br J Radiol. 2016 Jun 24:20150887.
    Abstract    

    Abstract available

  30. OLIVETO JM, Muinov L
    Cystic Cervicitis: A Case Report and Literature Review of Cystic Cervical Lesions.
    J Comput Assist Tomogr. 2016;40:564-6.
    Abstract    

    Abstract available

  31. VENEZUELA RF, Monetti MS, Kiguen AX, Frutos MC, et al
    Knowledge of the General Community in Cordoba, Argentina, on Human Papilloma Virus Infection and its Prevention.
    Asian Pac J Cancer Prev. 2016;17:2689-94.
    Abstract    

    Abstract available

  32. BEKMUKHAMBETOV Y, Balmagambetova S, Jarkenov T, Nurtayeva S, et al
    Distribution of High Risk Human Papillomavirus Types in Western Kazakhstan - Retrospective Analysis of PCR Data.
    Asian Pac J Cancer Prev. 2016;17:2667-72.
    Abstract    

    Abstract available

  33. HERNOWO BS, Suryanti S, Wibisono F
    Correlation between EGFR Expression and Radiosensitivity in Cervical Adenocarcinoma Cases.
    Asian Pac J Cancer Prev. 2016;17:2535-7.
    Abstract    

    Abstract available

  34. VAPIWALA N
    Replacing Urban Myths About Cancer With Community Wisdom: Putting a Finger on Cancer Disparities.
    JAMA Oncol. 2016;2:996-8.
    Abstract    



  35. PASKETT ED, Krok-Schoen JL, Pennell ML, Tatum CM, et al
    Results of a Multilevel Intervention Trial to Increase Human Papillomavirus (HPV) Vaccine Uptake among Adolescent Girls.
    Cancer Epidemiol Biomarkers Prev. 2016;25:593-602.
    Abstract    

    Abstract available

  36. LIU B, Gao S, Li S
    A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A Meta-Analysis Based on 67 Studies.
    Gynecol Obstet Invest. 2017 Feb 10. doi: 10.1159/000456006.
    Abstract    

    Abstract available

  37. KONG Q, Tang Z, Xiang F, Jiang J, et al
    Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
    Clin Lab. 2017;63:335-340.
    Abstract    

    Abstract available

  38. GOL I, Erkin O
    Knowledge and practices of nurses on cervical cancer, HPV and HPV vaccine in Cankiri state hospital, Turkey.
    J Pak Med Assoc. 2016;66:1621-1626.
    Abstract    

    Abstract available


  39. Cervical Cancer Analysis Reveals New Mutations.
    Cancer Discov. 2017 Feb 8. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract    

    Abstract available

  40. CANTRELL LA, Duska LR
    PET trumps surgical staging in locally advanced cervical cancer.
    BJOG. 2017 Feb 8. doi: 10.1111/1471-0528.14595.
    Abstract    

    Abstract available

  41. ZHANG J, Liu J, Zhu C, He J, et al
    Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis.
    Oncotarget. 2017 Feb 3. doi: 10.18632/oncotarget.15044.
    Abstract    

    Abstract available

  42. BURTON-JEANGROS C, Cullati S, Manor O, Courvoisier DS, et al
    Cervical cancer screening in Switzerland: cross-sectional trends (1992-2012) in social inequalities.
    Eur J Public Health. 2017;27:167-173.
    Abstract    



  43. FANTINI J, Sartori A, Manganotti P
    Avoiding misdiagnosis: cystic calcified brain metastases of uterine cervical cancer mimicking neurocysticercosis.
    BMJ Case Rep. 2017;2017.
    Abstract    

    Abstract available

  44. VAZQUEZ-MOROMICRONN JM, Cabello Fernandez A, Pallares-Manrique H, Ramos-Lora M, et al
    P693 Patients with inflammatory bowel disease who are on immunosuppressive therapy perform regular gynecologic screening for uterine cervical cancer?
    J Crohns Colitis. 2017;11.
    Abstract    



  45. BHANU PRASAD V, Mallick S, Rath GK
    Patterns of care of cervical cancer in the elderly: A qualitative literature review.
    J Geriatr Oncol. 2017 Feb 3. pii: S1879-4068(16)30169.
    Abstract    

    Abstract available

  46. LOPEZ MS, Baker ES, Maza M, Fontes-Cintra G, et al
    Cervical cancer prevention and treatment in Latin America.
    J Surg Oncol. 2017 Feb 7. doi: 10.1002/jso.24544.
    Abstract    

    Abstract available

  47. BARTELLAS M, Ryan S, Doucet G, Murphy D, et al
    Three-Dimensional Printing of a Hemorrhagic Cervical Cancer Model for Postgraduate Gynecological Training.
    Cureus. 2017;9:e950.
    Abstract    

    Abstract available

  48. BUCHANAN LUNSFORD N, Ragan K, Lee Smith J, Saraiya M, et al
    Environmental and Psychosocial Barriers to and Benefits of Cervical Cancer Screening in Kenya.
    Oncologist. 2017 Feb 6. pii: theoncologist.2016-0213.
    Abstract    

    Abstract available

  49. ZHOU C, Tan DM, Chen L, Xu XY, et al
    Effect of miR-212 targeting TCF7L2 on the proliferation and metastasis of cervical cancer.
    Eur Rev Med Pharmacol Sci. 2017;21:219-226.
    Abstract    

    Abstract available

  50. GUO P, Almubarak H, Banerjee K, Stanley RJ, et al
    Enhancements in localized classification for uterine cervical cancer digital histology image assessment.
    J Pathol Inform. 2016;7:51.
    Abstract    

    Abstract available

  51. BURKI TK
    Novel mutations in cervical cancer.
    Lancet Oncol. 2017 Feb 2. pii: S1470-2045(17)30080.
    Abstract    



  52. BENITO V, Carballo S, Silva P, Esparza M, et al
    Should the Presence of Metastatic Para-aortic Lymph Nodes in Locally Advanced Cervical Cancer Lead to More Aggressive Treatment Strategies?
    J Minim Invasive Gynecol. 2017 Feb 1. pii: S1553-4650(17)30092.
    Abstract    

    Abstract available

  53. FLOWER E, Do V, Sykes J, Dempsey C, et al
    Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose-volume histogram parameter reproducibility and anatomic position stability.
    Brachytherapy. 2017 Feb 1. pii: S1538-4721(16)30647.
    Abstract    

    Abstract available

  54. XIA YF, Pei GH, Wang N, Che YC, et al
    miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Virol J. 2017;14:20.
    Abstract    

    Abstract available

  55. WU S, Sun J, Lian J, Shang H, et al
    Macrophage migration inhibitory factor promoter polymorphisms (-794CATT5-7 ) as potential biomarker for early-stage cervical cancer.
    J Obstet Gynaecol Res. 2017 Feb 4. doi: 10.1111/jog.13233.
    Abstract    

    Abstract available

  56. BACORRO W, Dumas I, Levy A, Rivin Del Campo E, et al
    Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer.
    Brachytherapy. 2017 Jan 31. pii: S1538-4721(16)30616.
    Abstract    

    Abstract available

  57. KELLY-HANKU A, Ase S, Fiya V, Toliman P, et al
    Ambiguous bodies, uncertain diseases: knowledge of cervical cancer in Papua New Guinea.
    Ethn Health. 2017 Feb 3:1-23. doi: 10.1080/13557858.2017.1283393.
    Abstract    

    Abstract available

  58. HASAHYA OT, Berggren V, Sematimba D, Nabirye RC, et al
    Beliefs, perceptions and health-seeking behaviours in relation to cervical cancer: a qualitative study among women in Uganda following completion of an HPV vaccination campaign.
    Glob Health Action. 2016;9:29336.
    Abstract    

    Abstract available

  59. AKINLOTAN M, Bolin JN, Helduser J, Ojinnaka C, et al
    Cervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured Women.
    J Community Health. 2017 Feb 2. doi: 10.1007/s10900-017-0316.
    Abstract    

    Abstract available

  60. KIMMIG R, Buderath P, Rusch P, Aktas B, et al
    Surgical anatomy of the ligamentous mesometrium and robotically assisted ICG-guided resection in cervical cancer.
    Gynecol Oncol Rep. 2017;20:4.
    Abstract    

    Abstract available

  61. ADEPOJU EG, Ilori T, Olowookere SA, Idowu A, et al
    Targeting women with free cervical cancer screening: challenges and lessons learnt from Osun state, southwest Nigeria.
    Pan Afr Med J. 2016;24:319.
    Abstract    

    Abstract available

  62. JOURA EA, Pils S
    Vaccines against human papillomavirus infections: protection against cancer, genital warts or both?
    Clin Microbiol Infect. 2016;22 Suppl 5:S125-S127.
    Abstract    

    Abstract available

  63. WANG F, Li L, Liu B, Chen Z, et al
    Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Biomed Pharmacother. 2017;86:595-604.
    Abstract    

    Abstract available

  64. DE MATOS LG, Candido EB, Vidigal PV, Bordoni PH, et al
    Association between Toll-like receptor and tumor necrosis factor immunological pathways in uterine cervical neoplasms.
    Tumori. 2017;103:81-86.
    Abstract    

    Abstract available

  65. CHO SH, Hong JH, Noh YW, Lee E, et al
    Raspberry-like poly(gamma-glutamic acid) hydrogel particles for pH-dependent cell membrane passage and controlled cytosolic delivery of antitumor drugs.
    Int J Nanomedicine. 2016;11:5621-5632.
    Abstract    

    Abstract available

  66. ANANTAWORAPOT A, Manusook S, Tanprasertkul C, Lertvutivivat S, et al
    Clinical Factors Associated with Specimen Adequacy for Conventional Cervical Cytology in Thammasat University Hospital, Thailand.
    Asian Pac J Cancer Prev. 2016;17:4209-4212.
    Abstract    

    Abstract available

  67. ZHOU J, Wu SG, Sun JY, Li FY, et al
    Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
    J Cancer Res Clin Oncol. 2017;143:115-122.
    Abstract    

    Abstract available

  68. VENTUROLI S, Costa S, Barbieri D, Falasca A, et al
    Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma.
    Diagn Microbiol Infect Dis. 2016;86:270-272.
    Abstract    

    Abstract available

  69. ILAHI NE, Hashmi SN, Anwar S, Murad S, et al
    Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.
    J Cancer Res Clin Oncol. 2016;142:2367-73.
    Abstract    

    Abstract available

  70. KANTHIYA K, Khunnarong J, Tangjitgamol S, Puripat N, et al
    Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
    Asian Pac J Cancer Prev. 2016;17:3201-6.
    Abstract    

    Abstract available

  71. HUSSEIN NR, Balatay AA, Assafi MS, AlMufty TA, et al
    High Risk Human Papilloma Virus Genotypes in Kurdistan Region in Patients with Vaginal Discharge.
    Asian Pac J Cancer Prev. 2016;17:3191-3.
    Abstract    

    Abstract available

  72. CHANDRASEKARAN KS, Sathyanarayanan A, Karunagaran D
    Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.
    Tumour Biol. 2016;37:13155-13166.
    Abstract    

    Abstract available

  73. SAVONE D, Carrone A, Riganelli L, Merlino L, et al
    Management of HPV-related cervical disease: role of p16INK4a immunochemistry. Review of the literature.
    Tumori. 2016;102:450-458.
    Abstract    

    Abstract available

  74. GAMMON B, Gammon BR, Kim YH, Kim J, et al
    Neurotropic Gamma-Delta T-Cell Lymphoma With CD30-Positive Lymphoid Infiltrates.
    Am J Dermatopathol. 2016;38:e133-6.
    Abstract    

    Abstract available

  75. CHOI JS, Park S
    A study on the predictors of Korean male students' intention to receive human papillomavirus vaccination.
    J Clin Nurs. 2016;25.
    Abstract    

    Abstract available

  76. SCHIFFNER TA, Buki LP, Sabet RF
    Mexican American College Men's (Mis)Understandings About HPV and Cervical Cancer.
    Fam Community Health. 2017;40:150-159.
    Abstract    

    Abstract available

  77. VIVIANO M, DeBeaudrap P, Tebeu PM, Fouogue JT, et al
    A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa.
    Int J Womens Health. 2017;9:69-79.
    Abstract    

    Abstract available

  78. LIU B, Han L, Liu J, Han S, et al
    Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.
    Int J Nanomedicine. 2017;12:955-968.
    Abstract    

    Abstract available

  79. ZHOU J, Wu SG, Sun JY, Liao XL, et al
    Incorporation of the number of positive lymph nodes leads to better prognostic discrimination of node-positive early stage cervical cancer.
    Oncotarget. 2017 Feb 9. doi: 10.18632/oncotarget.15220.
    Abstract    

    Abstract available

  80. CLIFFORD GM, Tully S, Franceschi S
    Carcinogenicity of human papillomavirus types in HIV-positive women: A meta-analysis from HPV infection to cervical cancer.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    Abstract    




  81. Black women at higher risk of dying from cervical cancer.
    Nurs Stand. 2017;31:17.
    Abstract    

    Abstract available

  82. ROZEMEIJER K, Naber SK, Penning C, Overbeek LI, et al
    Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.
    BMJ. 2017;356:j504.
    Abstract    

    Abstract available

  83. TRAPERO-BERTRAN M, Acera Perez A, de Sanjose S, Manresa Dominguez JM, et al
    Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study.
    BMC Public Health. 2017;17:194.
    Abstract    

    Abstract available

  84. YANG H, Zhang H, Zhong Y, Wang Q, et al
    Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer.
    Sci Rep. 2017;7:41670.
    Abstract    

    Abstract available

  85. VURAL C, Bayrak BY, Muezzinoglu B, Yucesoy I, et al
    Perineural invasion is a valuable prognostic factor in advanced stage and/or Node (+) cervical cancer.
    Indian J Pathol Microbiol. 2017;60:27-32.
    Abstract    

    Abstract available

  86. SOUZA RP, Bonfim-Mendonca PS, Gimenes F, Ratti BA, et al
    Oxidative Stress Triggered by Apigenin Induces Apoptosis in a Comprehensive Panel of Human Cervical Cancer-Derived Cell Lines.
    Oxid Med Cell Longev. 2017;2017:1512745.
    Abstract    

    Abstract available

  87. TAKEKUMA M, Kasamatsu Y, Kado N, Kuji S, et al
    The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review.
    J Obstet Gynaecol Res. 2017 Feb 11. doi: 10.1111/jog.13282.
    Abstract    

    Abstract available

  88. HUANG QT, Man QQ, Hu J, Yang YL, et al
    Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies.
    Oncotarget. 2017 Feb 6. doi: 10.18632/oncotarget.15157.
    Abstract    

    Abstract available

  89. AN Z, Yu JR, Park WY
    Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells.
    Radiat Environ Biophys. 2017 Feb 9. doi: 10.1007/s00411-016-0679.
    Abstract    

    Abstract available

  90. MODIBBO F, Iregbu KC, Okuma J, Leeman A, et al
    Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria.
    Infect Agent Cancer. 2017;12:11.
    Abstract    

    Abstract available

  91. DYKENS JA, Linn AM, Irwin T, Peters KE, et al
    Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers.
    Int J Womens Health. 2017;9:59-67.
    Abstract    

    Abstract available

  92. VAIDAKIS D, Moustaki I, Zervas I, Barbouni A, et al
    Knowledge of Greek adolescents on human papilloma virus (HPV) and vaccination: A national epidemiologic study.
    Medicine (Baltimore). 2017;96:e5287.
    Abstract    

    Abstract available

  93. REVATHIDEVI S, Manikandan M, Rao AK, Vinothkumar V, et al
    Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation.
    Tumour Biol. 2016;37:11983-11990.
    Abstract    

    Abstract available

  94. MOEINI S, Saeidi M, Fotouhi F, Mondanizdeh M, et al
    Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Arch Virol. 2016.
    Abstract    

    Abstract available

  95. DEEL CD, Allen RA, Holman LL, Zuna RE, et al
    Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case.
    Diagn Pathol. 2016;11:77.
    Abstract    

    Abstract available

  96. ZHANG L, Chen Q, Hu J, Chen Y, et al
    Expression of HIF-2alpha and VEGF in Cervical Squamous Cell Carcinoma and Its Clinical Significance.
    Biomed Res Int. 2016;2016:5631935.
    Abstract    

    Abstract available

  97. NAIK A, Gurjar OP, Gupta KL, Singh K, et al
    Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study.
    Cancer Radiother. 2016;20:370-6.
    Abstract    

    Abstract available

  98. SCRIVENER CG, Gornall R, Rolland P
    Simple vaginal trachelectomy as a fertility-sparing treatment to manage high-grade dyskaryosis following multiple large loop excision of the transformation zone.
    BMJ Case Rep. 2016;2016.
    Abstract    

    Abstract available

  99. LEITE PM, Tafuri L, Costa MZ, Lima MI, et al
    Evaluation of the p16 and Ki-67 Biomarkers as Predictors of the Recurrence of Premalignant Cervical Cancer Lesions after LEEP Conization.
    Rev Bras Ginecol Obstet. 2017 Feb 23. doi: 10.1055/s-0037-1598643.
    Abstract    

    Abstract available

  100. ZHANG F, Thakur K, Hu F, Zhang JG, et al
    10-Gingerol, a Phytochemical Derivative from Tongling White Ginger, Inhibits Cervical Cancer: Insights into the Molecular Mechanism and Inhibitory Targets.
    J Agric Food Chem. 2017 Feb 23. doi: 10.1021/acs.jafc.7b00095.
    Abstract    

    Abstract available

  101. HAN L, Li C, Wang J, He X, et al
    Iodine-125 radioactive seed tissue implantation as a remedy treatment for recurrent cervical cancer.
    J Cancer Res Ther. 2016;12.
    Abstract    

    Abstract available

  102. ROMAN-JIMENEZ G, Acosta O, Leseur J, Devillers A, et al
    Random forests to predict tumor recurrence following cervical cancer therapy using pre- and per-treatment 18F-FDG PET parameters.
    Conf Proc IEEE Eng Med Biol Soc. 2016;2016:2444-2447.
    Abstract    

    Abstract available

  103. RYAN HA, Neuber J, Song S, Beebe SJ, et al
    Effects of a non-thermal plasma needle device on HPV-16 positive cervical cancer cell viability in vitro.
    Conf Proc IEEE Eng Med Biol Soc. 2016;2016:537-540.
    Abstract    

    Abstract available

  104. DAMACENA AM, Luz LL, Mattos IE
    Cervical cancer screening in Teresina, Piaui, Brazil: evaluation study using data of the Cervical Cancer Information System, 2006-2013.
    Epidemiol Serv Saude. 2017;26:71-80.
    Abstract    

    Abstract available

  105. LEE EY, Perucho JA, Vardhanabhuti V, He J, et al
    Intravoxel incoherent motion MRI assessment of chemoradiation-induced pelvic bone marrow changes in cervical cancer and correlation with hematological toxicity.
    J Magn Reson Imaging. 2017 Feb 22. doi: 10.1002/jmri.25680.
    Abstract    

    Abstract available

  106. YANG K, Xia B, Wang W, Cheng J, et al
    A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer.
    Sci Rep. 2017;7:43353.
    Abstract    

    Abstract available

  107. AFZAL O, Lieber M, Dottino P, Beddoe AM, et al
    Cervical cancer screening in rural South Africa among HIV-infected migrant farm workers and sex workers.
    Gynecol Oncol Rep. 2017;20:18-21.
    Abstract    

    Abstract available

  108. CHO O, Noh OK, Oh YT, Chang SJ, et al
    Hematological parameters during concurrent chemoradiotherapy as potential prognosticators in patients with stage IIB cervical cancer.
    Tumour Biol. 2017;39:1010428317694306.
    Abstract    

    Abstract available

  109. TUNG WC, Lu M, Granner M
    Perceived Benefits and Barriers of Cervical Cancer Screening Among Chinese American Women.
    Oncol Nurs Forum. 2017;44:247-254.
    Abstract    

    Abstract available

  110. WEI M, Zhang YL, Chen L, Cai CX, et al
    [RNA interference of HERC4 inhibits proliferation, apoptosis and migration of cervical cancer Hela cells].
    Nan Fang Yi Ke Da Xue Xue Bao. 2016;37:232-237.
    Abstract    

    Abstract available

  111. WUERTZ BR, Darrah L, Wudel J, Ondrey FG, et al
    Thiazolidinediones abrogate cervical cancer growth.
    Exp Cell Res. 2017 Feb 17. pii: S0014-4827(17)30074.
    Abstract    

    Abstract available

  112. BINDU T, Kumar SS, Ratheesan K, Balasubramanian S, et al
    Factors associated with survival and lost to follow-up of cervical cancer patients in a tertiary cancer centre in rural Kerala.
    Indian J Public Health. 2017;61:43-46.
    Abstract    

    Abstract available

  113. PARK JY, Kim YM, Lee YY, Kim TJ, et al
    Laparoendoscopic single-site radical hysterectomy for early stage cervical cancer.
    Obstet Gynecol Sci. 2017;60:110-114.
    Abstract    

    Abstract available

  114. GRANADOS-LOPEZ AJ, Ruiz-Carrillo JL, Servin-Gonzalez LS, Martinez-Rodriguez JL, et al
    Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development.
    Int J Mol Sci. 2017;18.
    Abstract    

    Abstract available

  115. FUJIOKA H, Kato T, Sone M, Horita T, et al
    Study of Preoperative 3D-CT Angiography of Uterine Artery in Patients with Uterine Cervical Cancer.
    Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73:112-119.
    Abstract    

    Abstract available

  116. ZHENG Y, Hu B, Xie S, Chen X, et al
    Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
    Cytotherapy. 2017 Feb 15. pii: S1465-3249(17)30034.
    Abstract    

    Abstract available

  117. MATSUO K, Machida H, Blake EA, Takiuchi T, et al
    Significance of uterine corpus tumor invasion in early-stage cervical cancer.
    Eur J Surg Oncol. 2017 Feb 3. pii: S0748-7983(17)30112.
    Abstract    

    Abstract available

  118. KADOYA N, Miyasaka Y, Nakajima Y, Kuroda Y, et al
    Evaluation of deformable image registration between external beam radiotherapy and HDR brachytherapy for cervical cancer with a 3D-printed deformable pelvis phantom.
    Med Phys. 2017 Feb 18. doi: 10.1002/mp.12168.
    Abstract    

    Abstract available

  119. MOMBERG M, Botha MH, Van der Merwe FH, Moodley J, et al
    Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
    BMJ Open. 2017;7:e013914.
    Abstract    

    Abstract available

  120. CHENG J, Zeng Z, Ye Q, Zhang Y, et al
    The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis.
    Oncotarget. 2017 Feb 15. doi: 10.18632/oncotarget.15358.
    Abstract    

    Abstract available

  121. TIAN T, Li X, Hua Z, Ma J, et al
    S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition.
    Oncotarget. 2017 Feb 15. doi: 10.18632/oncotarget.15329.
    Abstract    

    Abstract available

  122. KANG AR, An HT, Ko J, Kang S, et al
    Ataxin-1 regulates epithelial-mesenchymal transition of cervical cancer cells.
    Oncotarget. 2017 Feb 14. doi: 10.18632/oncotarget.15319.
    Abstract    

    Abstract available

  123. MA X, Li Q, Wang JL, Shao J, et al
    Comparison of elastography based on transvaginal ultrasound and MRI in assessing parametrial invasion of cervical cancer.
    Clin Hemorheol Microcirc. 2017 Feb 17. doi: 10.3233/CH-16235.
    Abstract    

    Abstract available

  124. DU Z, Qu H
    The relationship between ovarian function and ovarian limited dose in radiotherapy postoperation of ovarian transposition in young patients with cervical cancer.
    Cancer Med. 2017 Feb 17. doi: 10.1002.
    Abstract    

    Abstract available

  125. CLEMENTE N, Alessandrini L, Vaccher E, De Paoli A, et al
    Multiple preinvasive and invasive HPV-related lesions of the anogenital tract in a female patient with HIV infection: A case report.
    Medicine (Baltimore). 2017;96:e5948.
    Abstract    

    Abstract available

  126. DAMIAN A, Lago G, Rossi S, Alonso O, et al
    Early Detection of Bone Metastasis in Small Cell Neuroendocrine Carcinoma of the Cervix by 68Ga-DOTATATE PET/CT Imaging.
    Clin Nucl Med. 2016 Dec 21. doi: 10.1097/RLU.0000000000001498.
    Abstract    

    Abstract available

  127. MAGNANI B, Harubin B, Katz JF, Zuckerman AL, et al
    See, Test & Treat: A 5-Year Experience of Pathologists Driving Cervical and Breast Cancer Screening to Underserved and Underinsured Populations.
    Arch Pathol Lab Med. 2016;140:1411-1422.
    Abstract    

    Abstract available

  128. GHOFRANI M, Zhao C, Davey DD, Fan F, et al
    Update on the College of American Pathologists Experience With High-Risk Human Papillomavirus Proficiency Testing for Cytology.
    Arch Pathol Lab Med. 2016;140:1371-1374.
    Abstract    

    Abstract available

  129. BARILLOT I, Haie-Meder C, Charra Brunaud C, Peignaux K, et al
    [Radiotherapy of cervix and endometrial carcinoma].
    Cancer Radiother. 2016;20 Suppl:S189-95.
    Abstract    

    Abstract available

  130. SINGH MP, Kaur M, Gupta N, Kumar A, et al
    Prevalence of high-risk human papilloma virus types and cervical smear abnormalities in female sex workers in Chandigarh, India.
    Indian J Med Microbiol. 2016;34:328-34.
    Abstract    

    Abstract available

  131. ZHAO C, Crothers BA, Ghofrani M, Li Z, et al
    Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey.
    Arch Pathol Lab Med. 2016;140:1364-1370.
    Abstract    

    Abstract available

  132. PAN DH, Zhu ML, Lin XM, Lin XG, et al
    Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China.
    Eur J Med Res. 2016;21:28.
    Abstract    

    Abstract available

  133. KAPOOR K, Evans MC, Shkullaku M, Schillinger R, et al
    Biventricular metastatic invasion from cervical squamous cell carcinoma.
    BMJ Case Rep. 2016;2016.
    Abstract    

    Abstract available

  134. YUAN CT, Lin MC, Kuo KT, Wang TH, et al
    Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
    Virchows Arch. 2016;469:351-6.
    Abstract    

    Abstract available

  135. BELFORT-MATTOS PN, Focchi GR, Ribalta JC, Megale De Lima T, et al
    Immunohistochemical Expression of VEGF and Podoplanin in Uterine Cervical Squamous Intraepithelial Lesions.
    Dis Markers. 2016;2016:8293196.
    Abstract    

    Abstract available

  136. WINFIELD JM, Orton MR, Collins DJ, Ind TE, et al
    Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRI.
    Eur Radiol. 2017;27:627-636.
    Abstract    

    Abstract available

  137. WANG X, Liu W, Xu Z, Wang F, et al
    Effect of Dexmedetomidine Alone for Intravenous Patient-Controlled Analgesia After Gynecological Laparoscopic Surgery: A Consort-Prospective, Randomized, Controlled Trial.
    Medicine (Baltimore). 2016;95:e3639.
    Abstract    

    Abstract available

  138. MAJDFAR Z, Khodadost M, Majlesi F, Rahimi A, et al
    Relationships between Self-Efficacy and Pap Smear Screening in Iranian Women.
    Asian Pac J Cancer Prev. 2016;17 Spec No.
    Abstract    

    Abstract available

  139. CATARINO R, Vassilakos P, Jinoro J, Broquet C, et al
    Human papillomavirus prevalence and type-specific distribution of high- and low-risk genotypes among Malagasy women living in urban and rural areas.
    Cancer Epidemiol. 2016;42:159-66.
    Abstract    

    Abstract available

  140. XUE Z, Zhu X, Teng Y
    Comparison of Nerve-Sparing Radical Hysterectomy and Radical Hysterectomy: a Systematic Review and Meta-Analysis.
    Cell Physiol Biochem. 2016;38:1841-50.
    Abstract    

    Abstract available

  141. MAITI A, Bhattacharya S
    A patient with cancer and nail pigmentation.
    BMJ. 2016;353:i2346.
    Abstract    



  142. THRALL MJ
    Effect of Lower Anogenital Squamous Terminology Recommendations on the Use of p16 Immunohistochemistry and the Proportion of High-Grade Diagnoses in Cervical Biopsy Specimens.
    Am J Clin Pathol. 2016;145:524-30.
    Abstract    

    Abstract available

  143. PRADHAN D, Li Z, Ocque R, Patadji S, et al
    Clinical significance of atypical glandular cells in Pap tests: An analysis of more than 3000 cases at a large academic women's center.
    Cancer Cytopathol. 2016;124:589-95.
    Abstract    

    Abstract available

  144. ADAMS-CAMPBELL LL, Dash C, Palmer JR, Wiedemeier MV, et al
    Predictors of biospecimen donation in the Black Women's Health Study.
    Cancer Causes Control. 2016;27:797-803.
    Abstract    

    Abstract available

  145. LORENZI AT, Fregnani JH, Possati-Resende JC, Antoniazzi M, et al
    Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?
    Cancer Cytopathol. 2016;124:581-8.
    Abstract    

    Abstract available

  146. WALLIN E, Floter Radestad A, Falconer H
    Introduction of robot-assisted radical hysterectomy for early stage cervical cancer: impact on complications, costs and oncologic outcome.
    Acta Obstet Gynecol Scand. 2017 Feb 10. doi: 10.1111/aogs.13112.
    Abstract    

    Abstract available

  147. VIRTANEN E, Kalliala I, Dyba T, Nieminen P, et al
    Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions.
    Acta Obstet Gynecol Scand. 2017;96:61-68.
    Abstract    

    Abstract available

  148. BAASLAND I, Hagen B, Vogt C, Valla M, et al
    Colposcopy and additive diagnostic value of biopsies from colposcopy-negative areas to detect cervical dysplasia.
    Acta Obstet Gynecol Scand. 2016;95:1258-1263.
    Abstract    

    Abstract available

  149. ASCIUTTO KC, Henic E, Darlin L, Forslund O, et al
    Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable.
    Acta Obstet Gynecol Scand. 2016;95:1251-1257.
    Abstract    

    Abstract available

  150. BHAGAT P, Susheilia S, Singh K, Sadhukhan S, et al
    Efficacy of modified rapid economic acetic acid-based Papanicolaou stain.
    Cytopathology. 2016;27:452-455.
    Abstract    

    Abstract available

  151. ABDULLGAFFAR B
    Clear cell carcinoma first suspected in Pap smear. The value of neutrophil cannibalism by tumor cells.
    Diagn Cytopathol. 2017;45:176-178.
    Abstract    



  152. AKHTAR I, Flowers R, Nuttli T, Nath V, et al
    Poorly differentiated squamous cell carcinoma of the cervix with sarcomatoid differentiation: Report of a case with cytohistological correlation.
    Diagn Cytopathol. 2017;45:137-142.
    Abstract    

    Abstract available

  153. DAVIS G, Anderson L, Pather S
    Extramammary paget's disease mimicking localized malignancy on cervical cytology.
    Diagn Cytopathol. 2016;44:931-934.
    Abstract    

    Abstract available

  154. RYU KJ, Lee S, Min KJ, Hong JH, et al
    Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.
    Diagn Cytopathol. 2016 Oct 7. doi: 10.1002/dc.23533.
    Abstract    

    Abstract available

  155. ALLISON DB, Olson MT, Maleki Z, Ali SZ, et al
    Metastatic urinary tract cancers in pap test: Cytomorphologic findings and differential diagnosis.
    Diagn Cytopathol. 2016;44:1078-1081.
    Abstract    

    Abstract available

  156. HO CK, Kornaga EN, Klimowicz AC, Enwere EK, et al
    Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
    Gynecol Oncol. 2017 Jan 25. pii: S0090-8258(16)31689.
    Abstract    

    Abstract available

  157. LAIRSON DR, Fu S, Chan W, Xu L, et al
    Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas.
    Gynecol Oncol. 2017 Feb 10. pii: S0090-8258(17)30122.
    Abstract    

    Abstract available

  158. SALVO G, Ramirez PT, Levenback CF, Munsell MF, et al
    Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Gynecol Oncol. 2017 Feb 7. pii: S0090-8258(17)30116.
    Abstract    

    Abstract available

  159. PETITNICOLAS C, Azais H, Ghesquiere L, Tresch-Bruneel E, et al
    Morbidity of Staging Inframesenteric Paraaortic Lymphadenectomy in Locally Advanced Cervical Cancer Compared With Infrarenal Lymphadenectomy.
    Int J Gynecol Cancer. 2017 Feb 4. doi: 10.1097/IGC.0000000000000921.
    Abstract    

    Abstract available

  160. GUBBI A, Kacheria S, Ahmad S, Stavitzski NM, et al
    Prognostic Significance of the Standardized Uptake Value of Pretherapeutic 18F-Labeled 2-Fluoro-2-Deoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000930.
    Abstract    

    Abstract available

  161. MABUCHI S, Kimura T
    Extraperitoneal Radical Trachelectomy With Pelvic Lymphadenectomy: A Novel Fertility-Preserving Option for Early Stage Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000918.
    Abstract    

    Abstract available

  162. KOENSGEN D, Sehouli J, Belau A, Weiss M, et al
    Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000894.
    Abstract    

    Abstract available

  163. TEOH D, Isaksson Vogel R, Hultman G, Monu M, et al
    Single Health System Adherence to 2012 Cervical Cancer Screening Guidelines at Extremes of Age and Posthysterectomy.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001895.
    Abstract    

    Abstract available

  164. RAMLOV A, Assenholt MS, Jensen MF, Gronborg C, et al
    Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer.
    Radiother Oncol. 2017 Feb 9. pii: S0167-8140(17)30040.
    Abstract    

    Abstract available

  165. GAO ZW, Wang HP, Lin F, Wang X, et al
    CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
    BMC Cancer. 2017;17:135.
    Abstract    

    Abstract available

  166. HONG D, Liu J, Hu Y, Lu X, et al
    Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16.
    BMC Cancer. 2017;17:136.
    Abstract    

    Abstract available

  167. DE FREITAS LM, Serafim RB, de Sousa JF, Moreira TF, et al
    Photodynamic therapy combined to cisplatin potentiates cell death responses of cervical cancer cells.
    BMC Cancer. 2017;17:123.
    Abstract    

    Abstract available


  168. Correction: Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study.
    PLoS One. 2017;12:e0172417.
    Abstract    

    Abstract available

  169. TEGUETE I, Dolo A, Sangare K, Sissoko A, et al
    Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.
    PLoS One. 2017;12:e0172661.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;